HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
News & Information
|
Official Releases

Official Releases

View All 2021
JAN
spacer
FEB
spacer
MAR
spacer
APR
spacer
MAY
spacer
JUN
spacer
JUL
spacer
AUG
spacer
SEP
spacer
OCT
spacer
NOV
spacer
DEC
#
October 2021 Back to top
FDA amends EUAs for all COVID-19 vaccines, allows for booster doses for Moderna and Janssen (Johnson and Johnson) vaccines. FDA allows for use of each of the available COVID-19 vaccines as a heterologous (or "mix and match") booster dose in eligible individuals.
FDA Approval - 10/20/21
Updated Vaccine Information Statements (VIS) for Hepatitis A, Hepatitis B, and Rotavirus vaccines have been posted. Also, an updated version of the multiple pediatric vaccine VIS, "Your Child's First Vaccines: What You Need to Know"
CDC – 10/15/2021
FDA approves expanded age indication for Flucelvax Quadrivalent (Seqirus Inc), now licensed for persons 6 months of age and older
FDA Approval – 10/14/2021
#
September 2021 Back to top
FDA authorizes booster dose of Pfizer-BioNTech COVID-19 Vaccine for aged 65 years and older, aged 18 through 64 at high risk of severe COVID-19, aged 18 through 64 who have institutional or occupational exposure to SARS-CoV-2
FDA Approval – 9/22/2021
ACIP revised interim recommendation to standard recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged 16 years and older for the prevention of COVID-19
ACIP Recommendations - 9/21/2021
#
August 2021 Back to top
Prevention and Control of Seasonal Influenza with Vaccines, 2021–22
ACIP Recommendations – 8/27/21
FDA approves COVID-19 vaccine Comirnaty (Pfizer-BioNTech) for individuals 16 and older. The EUA remains in effect for individuals 12 years of age and older and for the third dose for immunocompromised individuals 12 years of age and older.
FDA Approval – 8/23/21
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update ACIP, July 2021
ACIP Recommendations - 8/13/21
FDA approves Ticovac (Pfizer) a vaccine to prevent tick-borne encephalitis (TBE) vaccine in individuals 1 year of age and older.
FDA Approval – 8/13/21
FDA amends the emergency use authorizations (EUAs) for Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals
FDA Approval – 8/12/21
Updated Vaccine Information Statements (VIS) for DTaP, Hib, HPV, live attenuated influenza, inactivated influenza, MMR, MMRV, MenACWY, MenB, PCV13, Polio, Tdap, Td, and VAR have been posted
CDC – 8/6/21
#
July 2021 Back to top
FDA expands indication for Shingrix vaccine to adults aged 18 years and older who are immunocompromised
FDA Approval – 7/23/21
FDA approves Vaxneuvance (Merck & Co, Inc.) pneumococcal 15-valent conjugate vaccine for adults 18 years or older
FDA approval – 7/16/21
FDA revises fact sheets for Janssen COVID-19 Vaccine (Johnson & Johnson), adding Guillain-Barré syndrome (GBS) warning and revising thrombocytopenia warning
FDA Approval – 7/12/21
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from ACIP — US, June 2021
ACIP Recommendations - 7/6/21
#
June 2021 Back to top
FDA revised EUA mRNA (Pfizer) patient and provider fact sheets regarding the suggested increased risks of myocarditis and pericarditis following vaccination
FDA Approval - 6/25/21
FDA revised EUA mRNA (Pfizer) patient and provider fact sheets regarding the suggested increased risks of myocarditis and pericarditis following vaccination
FDA Approval - 6/25/21
FDA approves Prevnar 20 (Pfizer) pneumococcal 20-valent conjugate vaccine for adults 18 years or older
FDA approval - 6/9/21
#
May 2021 Back to top
ACIP Interim Recommendations for use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 years, US, May 2021
ACIP Recommendations - 5/14/21
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents
FDA - 5/10/21
#
March 2021 Back to top
ACIP Interim Recommendation for Use of Janssen (Johnson and Johnson) COVID-19 Vaccine - U.S., February 2021
ACIP Recommendations - 3/2/2021
#
February 2021 Back to top
FDA issues emergency use authorization (EUA) for single dose COVID-19 Janssen (Johnson and Johnson) vaccine.
2/27/21
2021 U.S. Recommended Immunization Schedules for Children and Adolescents Age 18 Years or Younger
ACIP/AAP/AAFP/ACOG Recommendations - 2/12/21
2021 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
ACIP/AAFP/ACP/ACOG/ACNM - 2/12/21
#
January 2021 Back to top
Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, U.S., 2020
ACIP Recommendations - 1/8/21
Official Releases
News & Information Home
View All
- ACIP: Advisory Committee on Immunization Practices
- CDC: Centers for Disease Control and Prevention
- FDA: Food and Drug Administration
- 2020 Archive
- 2019 Archive
- 2018 Archive
- 2017 Archive
- 2016 Archive
- 2015 Archive
Additional Information
Vaccine Policy & Licensure
One-stop shop for official information about vaccines
State Immunization Information
Health department websites and managers, and laws
VIEW ALL:
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
 
This page was updated on October 22, 2021.
This page was reviewed on January 7, 2021.
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Storage & Handling
Vaccination and COVID-19
Vaccine Recommendations
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
Vaccines: COVID-19
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IAC EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Q&As: Easy-to-Read
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IAC EXPRESS
Subscribe to IAC Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
SLIDE SETS
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IAC EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
(ARCHIVE)
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
COVID-19
Hepatitis B
HPV (Human papillomavirus)
Influenza
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
•
•
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 1NH23IP922654) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.